1) bromodeoxyuridine(BrdU)
5-溴胱氧尿嘧啶核苷
2) BrdU
5-溴脱氧尿嘧啶核苷
1.
Technical explore on mesenchymal stem cells in bone marrow using BrdU labelling;
5-溴脱氧尿嘧啶核苷标记骨髓间充质干细胞的技术探讨
2.
Objective To study the feasibility of labeling adipose-derived adult stem cells with BrdU.
目的探讨5-溴脱氧尿嘧啶核苷(BrdU)标记脂肪成体干细胞(adipose-derived adult stem cells,ADASCs)的可行性。
3.
AIM: To study the differentiation characteristics and the optimal dosage and timing for bromodeoxyuridine (Brdu) labeling of rat bone marrow-derived mesenchymal stem cells (MSCs) in vitro.
目的:探讨骨髓间充质干细胞(MSCs)在体外的诱导分化及5-溴脱氧尿嘧啶核苷(Brdu)标记MSCs的可行性。
3) bromodeoxyuridine
['brəuməudi,ɔksi'juəridi:n]
5-溴脱氧尿嘧啶核苷
1.
To explore the best time and best dose for labeling the MSCs with bromodeoxyuridine(BrdU)in vitro,so as to attain the best tracing guide line of applying MSCs to future research.
目的 建立成人骨髓间充质干细胞(MSCs)体外分离培养和鉴定的方法,探讨连续培养的骨髓间充质干细胞应用5-溴脱氧尿嘧啶核苷(BrdU)标记的稳定性、最佳时间和剂量,争取确定应用骨髓间充质干细胞进行研究最好的示踪指标。
4) 5-bromodeoxyuridine
5-溴脱氧尿嘧啶核苷
1.
Study of 5-bromodeoxyuridine labeling of endothelial progenitor cells from the circulating blood from tooth movement rat
5-溴脱氧尿嘧啶核苷标记实验性牙移动大鼠血管内皮祖细胞的研究
2.
Methods The SNCs were isolated from sinus node tissues of rats by trypsin and purified cultured with differential attachment and 5-bromodeoxyuridine (BrdU) treatment.
方法取新生SD大鼠的窦房结组织,胰酶消化后采用速差贴壁法及5-溴脱氧尿嘧啶核苷(5-BrdU)纯化处理进行原代培养。
5) Doxifluridine
5'-脱氧-5-氟尿嘧啶核苷
6) bromodeoxyuridine
['brəuməudi,ɔksi'juəridi:n]
溴脱氧尿嘧啶核苷
1.
A study on the proliferation of oral cancer cell labelling using bromodeoxyuridine;
溴脱氧尿嘧啶核苷掺入标记口腔肿瘤的研究
2.
Apoptosis in gastric signet ring cell carcinomas induced by intermittent administration of bromodeoxyuridine;
目的 给带癌实验犬间歇性注射溴脱氧尿嘧啶核苷(BrdU)至49 h,观察BrdU诱发印戒细胞癌发生的凋亡变化。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条